Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen

Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen

US Patent 5840317 · Granted Nov 24, 1998

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mycobacterial immunotherapy for cancer treatment2013
35 kD tumor associated protein antigen: uses and methods of detection2006
Methods for lymph node identification2004
35 kD tumor associated protein antigen: uses and methods of detection2002
Adjuvant incorporation into antigen carrying cells: compositions and methods2001
Pluripotent vaccine against enveloped viruses2001
Tumor associated antigen compositions and methods1999
Polyvalent melanoma vaccine1999
Method of detection of urinary tumor associated antigen1997
Therapeutic treatment of abnormal cell growth with follicle regulatory protein1992
Therapeutic treatment of abnormal cell growth with follicle regulatory protein1989
Antigenic compositions and methods for using same1985